Creative Life Science Co

Creative Life Science Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of Creative Life Science Co (7837.TWO) as of Oct 17, 2026 is 5.01 M TWD. In the previous year, Stock-Based Compensation (SBC) was 4.77 M TWD — a change of 5.01% (higher).

Stock-Based Compensation

5.01 MTWD

YoY

5.01%

Last updated:

Stock-Based Compensation (SBC) of Creative Life Science Co is 2024 5.01 M TWD. Stock-Based Compensation (SBC) of Creative Life Science Co was 2023 4.77 M TWD. It decreases by 5.01% higher compared to the previous year.

The Creative Life Science Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2023
4.77 M TWD
Jan 1, 2024
5.01 M TWD
The Creative Life Science Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
5.01 MTWD+5.01%
4.77 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Creative Life Science Co Stock analysis

What does Creative Life Science Co do? Creative Life Science Co Ltd is a company based in Taipei, Taiwan, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 28, 2025, with the ticker 7837.TWO and ISIN TW0007837007. Creative Life Science develops and manufactures microbiological products, including its own brand, CMP, and acts as an agent for international brands. The CMP product range encompasses storage and carrying culture media, sterile transport containers, buffers and diluents, identification reagents, various culture media types, and selective culture media. The company also distributes dry powder culture media, detection reagents, in vitro diagnostic (IVD) culture media, sampling and transportation systems, and related products. Its offerings serve multiple sectors including pharmaceuticals, biotechnology, food, medical diagnosis, environmental monitoring, and academic research. The company provides testing, inspection, and certification services. Creative Life Science primarily focuses on the Taiwanese market for product distribution. The company's website is https://www.cmp-micro.com/. Creative Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Creative Life Science Co stock

Stock-Based Compensation (SBC) of Creative Life Science Co is 5.01 M TWD in 2024.

Stock-Based Compensation (SBC) of Creative Life Science Co changed from 4.77 M TWD to 5.01 M TWD, representing a 5.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Creative Life Science Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Creative Life Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Creative Life Science Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Creative Life Science Co